Search Results - "Croockewit, Sandra"

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells by Schreibelt, Gerty, Bol, Kalijn F, Westdorp, Harm, Wimmers, Florian, Aarntzen, Erik H J G, Duiveman-de Boer, Tjitske, van de Rakt, Mandy W M M, Scharenborg, Nicole M, de Boer, Annemiek J, Pots, Jeanette M, Olde Nordkamp, Michel A M, van Oorschot, Tom G M, Tel, Jurjen, Winkels, Gregor, Petry, Katja, Blokx, Willeke A M, van Rossum, Michelle M, Welzen, Marieke E B, Mus, Roel D M, Croockewit, Sandra A J, Koornstra, Rutger H T, Jacobs, Joannes F M, Kelderman, Sander, Blank, Christian U, Gerritsen, Winald R, Punt, Cornelis J A, Figdor, Carl G, de Vries, I Jolanda M

“…Thus far, dendritic cell (DC)-based immunotherapy of cancer was primarily based on in vitro-generated monocyte-derived DCs, which require extensive in vitro…”
Get full text

Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients by Bloemendal, Martine, Bol, Kalijn F., Boudewijns, Steve, Gorris, Mark A.J., de Wilt, Johannes H.W., Croockewit, Sandra A.J., van Rossum, Michelle M., de Goede, Anna L., Petry, Katja, Koornstra, Rutger H.T., Figdor, Carl, Gerritsen, Winald R., Schreibelt, Gerty, de Vries, I. Jolanda M.

“…We evaluated the immunological responses of lymph-node involved (stage III) melanoma patients to adjuvant dendritic cell vaccination with subsets of naturally…”
Get full text

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma by Bol, Kalijn F., MD, van den Bosch, Thomas, MD, PhD, Schreibelt, Gerty, PhD, Mensink, Hanneke W., MD, PhD, Keunen, Jan E.E., MD, PhD, Kiliç, Emine, MD, PhD, Japing, Wouter J., MD, Geul, Kaspar W., MD, Westdorp, Harm, MD, Boudewijns, Steve, MD, Croockewit, Sandra A.J., MD, PhD, van Rossum, Michelle M., MD, PhD, de Goede, Anna L., MD, PhD, Naus, Nicole C., MD, PhD, van der Graaf, Winette T.A., MD, PhD, Gerritsen, Winald R., MD, PhD, de Klein, Annelies, PhD, Punt, Cornelis J.A., MD, PhD, Figdor, Carl G., PhD, Cohen, Victoria M., MD, PhD, Paridaens, Dion, MD, PhD, de Vries, I. Jolanda M., PhD

Get full text

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity by Bol, Kalijn F., Aarntzen, Erik H. J. G., Pots, Jeanette M., Olde Nordkamp, Michel A. M., van de Rakt, Mandy W. M. M., Scharenborg, Nicole M., de Boer, Annemiek J., van Oorschot, Tom G. M., Croockewit, Sandra A. J., Blokx, Willeke A. M., Oyen, Wim J. G., Boerman, Otto C., Mus, Roel D. M., van Rossum, Michelle M., van der Graaf, Chantal A. A., Punt, Cornelis J. A., Adema, Gosse J., Figdor, Carl G., de Vries, I. Jolanda M., Schreibelt, Gerty

“…Dendritic cell (DC)-based immunotherapy is explored worldwide in cancer patients, predominantly with DC matured with pro-inflammatory cytokines and…”
Get full text

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial by Minnema, Monique C, Nasserinejad, Kazem, Hazenberg, Bouke, Hegenbart, Ute, Vlummens, Philip, Ypma, Paula F, Kröger, Nicolaus, Wu, Ka Lung, Kersten, Marie Jose, Schaafsma, M Ron, Croockewit, Sandra, de Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemieke, Koene, Harry, Bos, Gerard, Sonneveld, Pieter, Schönland, Stefan

“…This prospective, multicenter, phase II study investigated the use of four cycles of bortezomib-dexamethasone induction treatment, followed by high-dose…”
Get full text

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial by Bol, Kalijn F., Schreibelt, Gerty, Bloemendal, Martine, van Willigen, Wouter W., Hins-de Bree, Simone, de Goede, Anna L., de Boer, Annemiek J., Bos, Kevin J. H., Duiveman-de Boer, Tjitske, Olde Nordkamp, Michel A. M., van Oorschot, Tom G. M., Popelier, Carlijn J., Pots, Jeanne M., Scharenborg, Nicole M., van de Rakt, Mandy W. M. M., de Ruiter, Valeska, van Meeteren, Wilmy S., van Rossum, Michelle M., Croockewit, Sandra J., Koeneman, Bouke J., Creemers, Jeroen H. A., Wortel, Inge M. N., Angerer, Caroline, Brüning, Mareke, Petry, Katja, Dzionek, Andrzej, van der Veldt, Astrid A., van Grünhagen, Dirk J., Werner, Johanna E. M., Bonenkamp, Johannes J., Haanen, John B. A. G., Boers-Sonderen, Marye J., Koornstra, Rutger H. T., Boomsma, Martijn F., Aarntzen, Erik H. J., Gotthardt, Martin, Nagarajah, James, de Witte, Theo J. M., Figdor, Carl G., de Wilt, Johannes H. W., Textor, Johannes, de Groot, Jan Willem B., Gerritsen, Winald R., de Vries, I. Jolanda M.

“…Autologous natural dendritic cells (nDCs) treatment can induce tumor-specific immune responses and clinical responses in cancer patients. In this phase III…”
Get full text

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial by Scheid, Christof, Sonneveld, Pieter, Schmidt-Wolf, Ingo G H, van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Salwender, Hans, Zweegman, Sonja, Blau, Igor Wolfgang, Vellenga, Edo, Weisel, Katja, Pfreundschuh, Michael, Jie, Kon-Siong, Neben, Kai, van de Velde, Helgi, Duehrsen, Ulrich, Schaafsma, M Ron, Lindemann, Walter, Kersten, Marie José, Peter, Norma, Hänel, Mathias, Croockewit, Sandra, Martin, Hans, Wittebol, Shulamiet, Bos, Gerard Mj, van Marwijk-Kooy, Marinus, Wijermans, Pierre, Goldschmidt, Hartmut, Lokhorst, Henk M

“…Renal impairment is frequent in patients with multiple myeloma and is correlated with an inferior prognosis. This analysis evaluates the prognostic role of…”
Get full text

Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods by Jacobs, Joannes F M, de Kat Angelino, Corrie M, Brouwers, Huberdina M L M, Croockewit, Sandra A, Joosten, Irma, van der Molen, Renate G

“…Serum free light chain (sFLC) measurements are increasingly important in the context of screening for monoclonal gammopathies, prognostic stratification, and…”
Get more information

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients by Bol, Kalijn F, Figdor, Carl G, Aarntzen, Erik HJG, Welzen, Marieke EB, van Rossum, Michelle M, Blokx, Willeke AM, van de Rakt, Mandy WMM, Scharenborg, Nicole M, de Boer, Annemiek J, Pots, Jeanette M, olde Nordkamp, Michel AM, van Oorschot, Tom GM, Mus, Roel DM, Croockewit, Sandra AJ, Jacobs, Joannes FM, Schuler, Gerold, Neyns, Bart, Austyn, Jonathan M, Punt, Cornelis JA, Schreibelt, Gerty, de Vries, I Jolanda M

“…Autologous dendritic cell (DC) therapy is an experimental cellular immunotherapy that is safe and immunogenic in patients with advanced melanoma. In an attempt…”
Get full text

Carfilzomib, Pomalidomide, and Dexamethasone As Second‐line Therapy for Lenalidomide‐refractory Multiple Myeloma by Sonneveld, Pieter, Zweegman, Sonja, Cavo, Michele, Nasserinejad, Kazem, Broijl, Annemiek, Troia, Rosella, Pour, Ludek, Croockewit, Sandra, Corradini, Paolo, Patriarca, Francesca, Wu, Kalung, Droogendijk, Jolanda, Bos, Gerard, Hajek, Roman, Teresa Petrucci, Maria, Ypma, Paula, Zojer, Nicholas, Minnema, Monique C., Boccadoro, Mario

“…This phase 2 trial investigated reinduction with carfilzomib, pomalidomide, and dexamethasone (KPd) and continuous pomalidomide/dexamethasone in patients at…”
Get full text

P899: HOVON 104; LONG TERM FOLLOW‐UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS by Minnema, Monique, Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula, Lung Wu, Ka, José Kersten, Marie, Croockewit, Sandra, Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemiek, Schönland, Stefan

Get full text

HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients by Minnema, Monique C., Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula F., Wu, Ka Lung, Kersten, Marie Jose, Croockewit, Sandra, Zweegman, Sonja, Tick, Lidwine, Broijl, Annemiek, Koene, Harry, Bos, Gerard M. J., Sonneveld, Pieter, Schönland, Stefan O.

“…The HOVON 104 studied bortezomib‐dexamethasone induction therapy and autologous stem cell transplantation in 50 patients, of whom 35 received an autologous…”
Get full text

Predictors for successful PBSC collection on the fourth day of G‐CSF‐induced mobilization in allogeneic stem cell donors by van Oostrum, Anja, Zwaginga, Jaap Jan, Croockewit, Sandra, Overdevest, Jacqueline, Fechter, Mirjam, Ruiterkamp, Bart, Brand, Anneke, Netelenbos, Tanja

“…Peripheral blood stem cells (PBSCs) used for allogeneic transplantation are collected by apheresis after pre‐treatment of donors with G‐CSF. Using modern…”
Get full text

Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients by DE VRIES, I. Jolanda M, LESTERHUIS, W. Joost, FIGDOR, Carl G, PUNT, Cornelis J. A, SCHARENBORG, Nicole M, ENGELEN, Linda P. H, RUITER, Dirk J, GERRITSEN, Marie-Jeanne P, CROOCKEWIT, Sandra, BRITTEN, Cedrik M, TORENSMA, Ruurd, ADEMA, Gosse J

“…Purpose: We have investigated the capacity of immature and mature monocyte-derived DCs pulsed with melanoma-associated peptides (gp100 and tyrosinase) to…”
Get full text

Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry by Wester, Ruth, Dinmohamed, Avinash G., Holt, Bronno, Zweegman, Sonja, Minnema, Monique, Croockewit, Sandra, Levin, Mark‐David, Libourel, Eduard, Waal, Esther, Sonneveld, Pieter, Cornelissen, Jan, Blijlevens, Nicole, Broijl, Annemiek

“…Patients with relapsed and/or refractory multiple myeloma (RRMM) generally have limited treatment options and a poor prognosis. Previous trials demonstrated…”
Get full text

Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B‐cell Lymphoma by Berendsen, Madeleine R., Bladel, Diede A.G., Hesius, Eva, Berganza Irusquieta, Cristina, Rijntjes, Jos, Spriel, Annemiek B., Spek, Ellen, Pruijt, Johannes F.M., Kroeze, Leonie I., Hebeda, Konnie M., Croockewit, Sandra, Stevens, Wendy B.C., Krieken, J Han J.M., Groenen, Patricia J.T.A., Brand, Michiel, Scheijen, Blanca

“…Patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) occasionally develop diffuse large B‐cell lymphoma (DLBCL). This mostly results…”
Get full text

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses by Haroche, Julien, Charlotte, Frédéric, Arnaud, Laurent, von Deimling, Andreas, Hélias-Rodzewicz, Zofia, Hervier, Baptiste, Cohen-Aubart, Fleur, Launay, David, Lesot, Annette, Mokhtari, Karima, Canioni, Danielle, Galmiche, Louise, Rose, Christian, Schmalzing, Marc, Croockewit, Sandra, Kambouchner, Marianne, Copin, Marie-Christine, Fraitag, Sylvie, Sahm, Felix, Brousse, Nicole, Amoura, Zahir, Donadieu, Jean, Emile, Jean-François

“…Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis. BRAF mutations have been observed in Langerhans cell histiocytosis…”
Get full text

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients by TEL, Jurjen, AARNTZEN, Erik H. J. G, WINKELS, Gregor, COULIE, Pierre G, PUNT, Cornelis J. A, FIGDOR, Carl G, DE VRIES, I. Jolanda M, BABA, Tetsuro, SCHREIBELT, Gerty, SCHULTE, Barbara M, BENITEZ-RIBAS, Daniel, BOERMAN, Otto C, CROOCKEWIT, Sandra, OYEN, Wim J. G, VAN ROSSUM, Michelle

“…Vaccination against cancer by using dendritic cells has for more than a decade been based on dendritic cells generated ex vivo from monocytes or CD34(+)…”
Get full text

Carfilzomib, Pomalidomide and Dexamethasone (KPd) in Patients with First Progression of Multiple Myeloma Refractory to Bortezomib and Lenalidomide. Final Report of the EMN011/HOVON114 Trial by Sonneveld, Pieter, Zweegman, Sonja, Cavo, Michele, Nasserinejad, Kazem, Broyl, Annemiek, Troia, Rosella, Pour, Ludek, Croockewit, Sandra, Corradini, Paolo, Bos, Gerard M.J., Wu, Ka Lung, Droogendijk, Jolanda, Minnema, Monique C., Boccadoro, Mario

“…Introduction and background Treatment of newly diagnosed Multiple Myeloma (MM) with Bortezomib, Imid and Dexamethasone followed by high-dose therapy and…”
Get full text

Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA) by van de Donk, Niels W C J, Otten, Henny G, El Haddad, Omar, Axel, Amy, Sasser, A Kate, Croockewit, Sandra, Jacobs, Joannes F M

“…Daratumumab is a fully human anti-CD38 IgG1-κ monoclonal antibody (mAb) currently being evaluated in several Phase 2 and 3 clinical studies for the treatment…”
Get more information